Telehealth to indentify the risk of stroke
Cardionetics is a Berkshire based developer of innovative medical devices designed to assist in the diagnosis of cardiovascular diseases. It uses artificial intelligence originally researched at Brunel University to identify and classify abnormal rhythms of the heart quickly and efficiently, allowing patients to be diagnosed earlier and treated more effectively. It recently launched its second-generation design of monitor, the C.Net5000 that is being widely used in the UK in primary care to benefit both patients and doctors alike.
In response to market requests Cardionetics was seeking a way to embrace telehealth and approached FASILIS to assist in investigating the feasibility of remotely monitor patients in the home. Remote diagnosis would in this way revolutionise the management of patients with heart disease, and at the same time help identify patients at risk of stroke. Heart disease and stroke are some of the most prevalent and harmful diseases known to man.
Cardionetics partners with Philips Applied Technology
With the assistance of FASILIS, Cardionetics partnered with Philips Applied Technology in Eindoven to add a wireless capability to the latest heart monitor and develop a proof of concept that could be trialled with experts in the medical field; Philips has extensive experience in the medical device field and already supplies a wide range of medical products to markets around the World.
Following the successful integration of wireless into the monitor the next step will be to turn the “proof of concept” into a number of devices for wider evaluation and gain feedback from users in a clinical setting; based on this a new variant of the existing monitor will be released into the telehealth market.